170634 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Sub-classes:PDK4 as a Cell-Aging Intervention Target and Its Use in Chemotherapy and Anticancer
#2USE OF DISCOIDIN DOMAIN RECEPTOR 2 IN DIAGNOSIS OF NEURODEGENERATIVE DISEASES, AND RELATED COMPUTER READABLE MEDIUM
#3REAGENT FOR MEASURING TYROSINE KINASE ACTIVITY, AND USE THEREOF
#4METHODS TO DETERMINE DRUG TARGET RESIDENCE TIME AND TO SELECT BEST DRUG-TARGET CANDIDATES
#5MULTIPLE BIOMARKER FOR CANCER DIAGNOSIS AND USE THEREOF
#6METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#7METHODS AND SYSTEMS FOR CHARACTERIZING PROTEOFORMS OF SIGNIFICANT PROTEINS OF INTEREST
#8BIOMARKERS
#9INHIBITORY AGENT FOR MYOCARDIAL CELL DEATH, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR MYOCARDIAL DISORDERS OR HEART FAILURE
#10COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#11METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#12METHODS OF OPTIMIZING KINASE INHIBITORS
#13DIAGNOSTIC INDICES FOR NEURODEGENERATIVE CONDITIONS
#14COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS
#15Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations
#16DIAGNOSTIC METHOD
#17TAG/ANTI-TAG SYSTEM FOR SIGNAL AMPLIFICATION IN IMMUNOASSAYS
#18DIAGNOSTICHOME KIT TODETECTMIDKINE LEVELIN BLOOD
#19MODULAR BIOSENSOR FOR RECEPTOR TYROSINE KINASE ACTIVITY
#20QUANTIFICATION OF LIGAND BIAS AND MUTATION-INDUCED SIGNALING BIAS IN EGFR PHOSPHORYLATION IN DIRECT RESPONSE TO LIGAND BINDING
#21Combination Of Proteotypic Peptides For The Detection Of Proteins In The Pd-L1 Axis
#22METHODS FOR IMPROVING OUTCOMES FOR HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS AT RISK FOR BRONCHIOLITIS OBLITERANS SYNDROME
#23BIOSENSOR AND USES THEREOF
#24METHODS OF TREATING CHOLANGIOCARCINOMA
#25ANTI-HER2/NEU ANTIBODIES AND METHODS OF USE
#26SYSTEMS AND METHODS TO IDENTIFY AND TREAT SUBJECTS AT RISK FOR OBSTETRICAL COMPLICATIONS
#27SUBSTITUTED FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USES THEREOF
#28ACTIVATED RAS AS THERAPEUTIC AND DIAGNOSTIC TARGET FOR NEUROFIBROMATOSIS AND USE THEREOF
#29MEANS AND METHODS APPLYING sFlt-1/PIGF OR ENDOGLIN/PIGF RATIO TO RULE OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
#30Kinase Activity In Tumors
#31BISTABLE POLYNUCLEOTIDE DEVICES FOR THE SENSING AND QUANTIFICATION OF MOLECULAR EVENTS
#32METHODS OF PREPARING AND ANALYZING SAMPLES FOR BIOMARKERS ASSOCIATED WITH PLACENTA ACCRETA
#33BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#34Unique and Selective Targeting of CDK Activity in Aggressive Carcinomas
#35METHODS FOR DIAGNOSING AND/OR TREATING ALZHEIMER'S DISEASE
#36ANTI-RELATED-TO-RECEPTOR TYROSINE KINASE (RYK) ANTIBODIES AND USES THEREOF
#37ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS
#38ANTI-EPHA4 ANTIBODY
#39METHODS FOR TREATING A SUBTYPE OF COLORECTAL CANCER
#40ANTI-CK2a ANTIBODY OR A FRAGMENT THEREOF
#41ANTI-POLYUBIQUITIN MULTISPECIFIC ANTIBODIES
#42BIOMARKERS FOR PARKINSON'S DISEASE
#43LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
#44METHODS OF DETERMINING RISK OF AND TREATING CANCER RECURRENCE
#45FUNCTIONALIZED NANOPARTICLES
#46Mature-Hepatocyte Transdifferentiation Suppressing Composition
#47COMPOUNDS FOR TARGETED PROTEIN DEGRADATION OF KINASES
#48Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
#49BIOMARKERS AND USES THEREOF
#50ANTIBODIES AGAINST ALK AND METHODS OF USE THEREOF
#51COVALENT APTAMERS
#52METHOD OF PROGNOSING PREECLAMPSIA
#53FOCAL ADHESION KINASE SPLICING ISOMER AND APPLICATION THEREOF
#54Methods of Identifying Active Lupus Nephritis Flare
#55METHODS OF MODULATING ALK
#56METHOD AND KIT FOR PREDICTING PREECLAMPSIA
#57COMPOSITIONS AND METHODS FOR TREATING INDIVIDUALS WHO HAVE ONCOGENE-NEGATIVE CANCER
#58COMPOSITION FOR DIFFERENTIAL DIAGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
#59CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS
#60WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH
#61METHODS AND COMPOSITIONS FOR PROTEIN FINGERPRINTING
#62NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT
#63A METHOD OF PREVENTING, ALLEVIATING OR TREATING A TUMOR
#64MONOCLONAL ANTIBODIES AGAINST C-MET
#65HER2 ANTIBODY AND APPLICATION THEREOF
#66ANALYSIS OF PROTEIN KINASES IN LIVE CELLS
#67USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#68METHODS AND RELATED ASPECTS FOR DETECTING UNLABELED BIOMOLECULES
#69BASE MATERIAL FOR MANUFACTURING SENSOR FOR ANALYZING DETECTION OBJECT, SENSOR FOR ANALYZING DETECTION OBJECT, AND METHOD FOR ANALYZING DETECTION OBJECT
#70Methods of treating cholangiocarcinoma
#71BIOMARKER TEST WITH UNIFIED PIGMENTATION
#72BIOMARKERS FOR CBL, AND COMPOSITIONS AND METHODS FOR THEIR USE
#73KINASES AS BIOMARKERS FOR NEURODEGENERATIVE CONDITIONS
#74Systems and methods to identify and treat subjects at risk for obstetrical complications
#75[18F]-LABELED IMIDAZOPYRIDINE DERIVATIVES AS PET RADIOTRACER
#76MARKER OF CALCIUM-OVERLOAD-MEDIATED NEURONAL DEATH AND APPLICATION THEREOF
#77METHOD FOR DETECTING INFLAMMATION-RELATED PLATELET ACTIVATION
#78SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES
#79DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS
#80METHOD OF DIAGNOSING BREAST CANCER
#81LIVE CELL ENGAGEMENT ASSAY
#82COMPOSITIONS AND METHODS FOR IDENTIFICATION OF MODULATORS OF RAS PROTEIN COMPLEXES
#83Novel Cell Based Assay
#84LZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF PROTEIN KINASE C EPSILON (PKC-EPSILON PROTEIN LEVELS
#85DEVICES, ASSAYS AND METHODS OF TESTING PREECLAMPSIA
#86METHOD OF IDENTIFYING TREATMENT RESPONSIVE NON-SMALL CELL LUNG CANCER USING ANAPLASTIC LYMPHOMA KINASE (ALK) AS A MARKER
#87Polypeptide for targeting recognition of immune cells and application thereof
#88SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE
#89PROLINE HYDROXYLATION PRIMES PROTEIN KINASES FOR AUTOPHOSPHORYLATION AND ACTIVATION
#90Lymphocyte-Based PKCe Test for Alzheimer's Disease
#91ANTIBODY-BASED COMPOSITIONS FOR TARGETING TROPOMYOSIN RECEPTOR KINASE B (TRKB) ISOFORMS
#92MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS
#93Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer
#94Leucine-Rich Repeat Kinase 2 Allosteric Modulators
#95COMPOSITION FOR CANCER DIAGNOSIS
#96PREDICTING PATIENT SURVIVAL
#97Compositions targeting the interaction domain between p27KIP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#98Combinatorial MAP Antibody Tests for Detection and Diagnosis
#99BIOMARKERS FOR THE DIAGNOSIS OF ATRIAL FIBRILLATION CAUSE OF STROKE
#100CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS
#101METHODS AND COMPOSITIONS FOR THE DETECTION, DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER
#102METHOD FOR ASSESSING DIFFERENTIATION STATE OF CELLS AND GELATIN NANOPARTICLES
#103BIOMARKERS OF THERAPEUTIC RESPONSIVENESS
#104METHOD AND KIT FOR DETERMINING BENEFIT OF CHEMOTHERAPY
#105Modular point-of-care devices, systems, and uses thereof
#106PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#107Bistable polynucleotide devices for the sensing and quantification of molecular events
#108FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#109ANTI-ALK2 ANTIBODIES AND USES THEREOF
#110COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING FIBROSIS
#111BTK MUTATION AND IBRUTINIB RESISTANCE
#112CANCER TREATMENT USING MULTI-TARGETED KINASE INHIBITOR IN COMBINATION OF PROTEIN KINASE BIOMARKERS
#113BIOMARKER FOR PREDICTING RESPONSE TO ANTICANCER AGENT AND USE THEREOF
#114A METHOD FOR SCREENING A THERAPEUTIC AGENT FOR CANCER USING BINDING INHIBITOR OF CYCLIN-DEPENDENT KINASE 1 (CDK1)-CYCLIN B1 AND RETINOIC ACID RECEPTOR RESPONDER 1 (RARRES1) GENE KNOCKOUT ANIMAL MODEL
#115Method for diagnosis and subtyping of adult onset Still's disease
#116Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#117ROS KINASE IN LUNG CANCER
#118DYSREGULATION OF COVID-19 RECEPTOR ASSOCIATED WITH IBD
#119Crenolanib for Treating FLT3 Mutated Proliferative Disorders Associated Mutations
#120ANALYTIC METHOD AND KIT FOR DIAGNOSING ALCOHOL USE DISORDERS
#121Kinase Activity In Tumors
#122Preeclampsia biomarkers and related systems and methods
#123Compositions and Methods for Treating ALK-Mediated Cancer
#124Methods of treating cholangiocarcinoma
#125IDENTIFICATION, SELECTION AND USE OF HIGH CURATIVE POTENTIAL T CELL EPITOPES
#126Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
#127PLK1 TARGET PHOSPHORYLATION STATUS AND TREATMENT OF CANCER WITH PLK1 INHIBITORS
#128SENSITIZING CANCER TO DEATH RECEPTOR AGONISTS WITH KINASE INHIBITORS
#129DIAGNOSTICS OF MILD OR ADVERSED PERIODONTITIS
#130TEST FOR DETECTING MALIGNANT KIDNEY CANCER
#131METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#132Cyclic peptides as protein targeting agents
#133Treatment of necroptosis
#134Reagents and Methods for Breast Cancer Detection
#135Serine threonine kinase (AKT) degradation / disruption compounds and methods of use
#136METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#137Anti-KIT antibodies and uses thereof
#138Method of inhibiting constitutively active phosphorylated FLT3 kinase
#139Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
#140IMMUNOGENIC COMPOSITIONS AND USES THEREFOR
#141PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#142Method and system for identifying membrane proteins on extracellular vesicles
#143TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#144RET inhibitor
#145Anti-c-Met antibody and use thereof
#146Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
#147Monoclonal antibodies against c-Met
#148Methods of treating cancer harboring hemizygous loss of TP53
#149Agents and methods for treating and preventing seborrheic keratosis
#150Biomarker Panel For Diagnosing Cancer
#151DIAGNOSTIC AND THERAPEUTIC METHODS FOR KRAS POSITIVE CANCERS
#152PHOSPHORYLATION OF HISTONES AND USES THEREOF
#153DISTINGUISHING ANTAGONISTIC AND AGONISTIC ANTI B7-H1 ANTIBODIES
#154Identification, selection and use of high curative potential T cell epitopes
#155Bistable polynucleotide devices for the sensing and quantification of molecular events
#156DISCOVERY AND VALIDATION OF CANCER BIOMARKERS USING A PROTEIN ANALYSIS METHODOLOGY TO ANALYZE SPECIMENS
#157Compositions targeting the interaction domain between p27Kip1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#158Universal kinase substrates and methods of use thereof
#159METHODS FOR IDENTIFYING MODULATORS OF MEMBRANE POTENTIALS IN BIPOLAR DISORDER AND ATTENTION DEFICIT HYPERACTIVITY DISORDER
#160NOVEL ISOFORM OF ANAPLASTIC LYMPHOMA KINASE AND ITS USES
#161Systems and methods to identify and treat subjects at risk for obstetrical complications
#162NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#163SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein
#164Biomarkers of therapeutic responsiveness
#165NOVEL METHODS FOR TREATING CANCER
#166ULK1 inhibitors and methods using same
#167NOVEL NUCLEOSIDE ANALOGS AND USE THEREOF IN THERAPEUTIC TREATMENT
#168METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#169Methods of detecting DDR2 mutations
#170DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS)
#171Cell based assay
#172BTK mutation and ibrutinib resistance
#173ULK1 inhibitors and methods using same
#174Macrocyclic compounds as ROS1 kinase inhibitors
#175MUTATIONS IN THE BCR-ABL TYROSINE KINASE ASSOCIATED WITH RESISTANCE TO STI-571
#176ROS kinase in lung cancer
#177Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#178Methods of treating by administering anti-kit antibodies
#179DETECTION OF NEURODEGENERATIVE DISEASES
#180USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#181Macrocylic compounds as ROS1 kinase inhibitors
#182Vector and gene introduction agent for monitoring and visualizing cell differentiation using expression of micro RNA as indicator and monitoring and visualizing method using thereof
#183Cancer examination method and examination kit
#184Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor
#185METHODS OF DIAGNOSING AND TREATING B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
#186COMPOSITIONS AND METHODS THAT INVOLVE PROTEIN SCAFFOLDS THAT SPECIFICALLY BIND TO HEPATOCYTE GROWTH FACTOR RECEPTOR
#187Agents and methods for treating and preventing seborrheic keratosis
#188METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#189Methods for detection and eradication of myeloid leukemia stem cells
#190LYMPHOCYTE-BASED PKCe TEST FOR ALZHEIMER'S DISEASE
#191Kinase substrates and methods of use thereof
#192Reagents and Methods for Breast Cancer Detection
#193Cell based assay
#194METHODS OF CANCER TREATMENT
#195Electrochemical impedimetric biosensing microchip for real time telomerase activity detection
#196METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#197Modular point-of-care devices, systems, and uses thereof
#198Modular point-of-care devices, systems, and uses thereof
#199Using phage epitopes to profile the immune response
#200TREATMENT OF NEURODEGENERATIVE CONDITIONS USING PKC ACTIVATORS AFTER DETERMINING THE PRESENCE OF THE APOE4 ALLELE
#201Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#202NOVEL METHODS FOR TREATING CANCER
#203USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#204COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
#205Cell-based assay for determining mTOR activity
#206Compositions and methods for controlling vasculature
#207Method for screening pharmaceuticals for treatment of steatohepatitis using N-terminal dimerization of apoptosis signal-regulated kinase1
#208Anti-ROR1 antibodies
#209Crenolanib for treating FLT3 mutated proliferative disorders associated mutations
#210METHOD FOR TREATING TAU PROTEIN-MEDIATED DEGENERATIVE NEURONAL DISEASE
#211Biomarker panel for diagnosing cancer
#212Mutant Akt-specific capture agents, compositions, and methods of using and making
#213Method of inhibiting constitutively active phosphorylated FLT3 kinase
#214BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#215Methods of treating cancer harboring hemizygous loss of TP53
#216TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#217Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#218Synergistic cancer treatment
#219METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY
#220ALZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF THE ERK1/ERK2 PHOSPHORYLATION RATIO-ALZHEIMER'S DISEASE-SPECIFIC MOLECULAR BIOMARKERS (ADSMB)
#221Lateral flow device and method of use
#222Therapeutic compositions for breast cancer containing protein kinase D1 inhibitor
#223Compositions and methods for treating multiple myeloma
#224PRKACB FUSIONS
#225ULK1 inhibitors and methods using same
#226MONOCLONAL ANTIBODIES AGAINST C-MET
#227Carbidopa for the treatment of cancer
#228MONOCLONAL ANTIBODIES AGAINST C-MET
#229Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
#230PHOSPHORYLATION OF HISTONES AND USES THEREOF
#231MTOR kinase mutations and methods of use thereof
#232Curcumin-based compositions and methods of use thereof
#233Methods of treating breast cancer that overexpress AKT kinase
#234ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES
#235IDENTIFICATION OF MODULATORS OF BINDING PROPERTIES OF ANTIBODIES REACTIVE WITH A MEMBER OF THE INSULIN RECEPTOR FAMILY
#236Compositions for modulating cancer stem cells and uses therefor
#237Methods of detecting DDR2 mutations
#238Method of predicting obesity comprising measuring neurotensin
#239Modulation of PTPRA to treat arthritis
#240Systems and methods to identify and treat subjects at risk for obstetrical complications
#241MAP3K8 AS A MARKER FOR SELECTING A PATIENT AFFECTED WITH AN OVARIAN CANCER FOR A TREATMENT WITH A MEK INHIBITOR
#242BIOMARKERS OF THERAPEUTIC RESPONSIVENESS
#243Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding protein
#244Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
#245Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker
#246Discovery and validation of cancer biomarkers using a protein analysis methodology to analyze specimens
#247METHOD FOR EVALUATING QUALITY OF HUMAN MESENCHYMAL STEM CELL, AND MONOCLONAL ANTIBODY FOR USE IN SAID METHOD
#248Lymphangiogenesis inhibitors for cancer and for graft survival
#249Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways
#250TERT fusions
#251Soluble AXL receptor tyrosine kinase in the diagnosis of cancer
#252Predicting response to cancer therapy
#253Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
#254Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
#255PREDICTING AND REDUCING COGNITIVE DECLINE BASED ON GSK-3 LEVELS
#256METHOD AND DEVICE FOR STABILIZING OF PROTEINS
#257Distinguishing antagonistic and agonistic anti B7-H1 antibodies
#258RAF gene fusions
#259Polynucleotides encoding anti-KIT antibodies
#260Compositions targeting the interaction domain between p27KiP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#261SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) protein
#262Natural-killer/T-cell lymphoma (NKTCL) susceptibility prediction, diagnosis and therapy
#263CaMKK-β as a target for treating cancer
#264Method for detecting protein modifications using specific antibodies
#265Isoform of anaplastic lymphoma kinase and its uses
#266Modular point-of-care devices, systems, and uses thereof
#267Peptides derived from NCAPG2 and their use
#268Modular point-of-care devices, systems, and uses thereof
#269Biomarker for parkinson's disease and use thereof
#270Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation
#271Methods for identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
#272Predictive method for determining tissual radiosensitivity
#273USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
#274CONTEMPORANEOUS, HETEROGENEOUSLY-ORIENTED, MULTI-TARGETED THERAPEUTIC MODIFICATION AND/OR MODULATION OF DISEASE BY ADMINISTRATION OF SULFUR-CONTAINING, AMINO ACID-SPECIFIC SMALL MOLECULES
#275Decoy peptides inhibiting binding of AMIGO2 and 3-phosphoinositide-dependent kinase 1
#276LKB1 related diagnostics and treatments of cancer
#277METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER
#278Peptides derived from NCAPG2 and their use
#279Method for Detecting Lung Cancer
#280Pharmaceutical compositions and methods for treating cancer and biomarkers for drug screening
#281Methods for treating cancer
#282Methods of treating non-small cell lung carcinoma (NSCLC)
#283OPTICALLY ACTIVATED RECEPTORS
#284Assay for Detection of Transient Intracellular CA2+
#285Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#286Biomarker for MELK activity and methods of using same
#287Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#288ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#289FLUORESCENT PROTEIN BIOSENSORS TO PROBE THE CONFORMATIONAL ACTIVATION OF CDK/CYCLIN KINASES
#290METHODS FOR PROMOTING MOTOR NEURON SURVIVAL
#291Nucleic acid sequence segment for enhancing protein expression
#292METHODS OF DETERMINING BREAST CANCER PROGNOSIS
#293Modular point-of-care devices, systems, and uses thereof
#294Modular point-of-care devices, systems, and uses thereof
#295Modular point-of-care devices, systems, and uses thereof
#296Methods of diagnosing and treating B cell acute lymphoblastic leukemia
#297Method and system for determination of molecular interaction parameters
#298Methods of screening for Janus kinase 3 interacting compounds
#299METHOD TO PREDICT OR DIAGNOSE A COLORECTAL CANCER
#300Methods and means for treatment of osteoarthritis